Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetics and pharmacodynamics of a long-acting monoclonal antibody against malaria in African adults.

The Journal of clinical investigation·2026
Same author

Memory regulatory T cells reprogram into protective T<sub>FH</sub> cell-like effectors in recurrent malaria.

Nature immunology·2026
Same author

Integrated evaluation of antibody responses to mosquitoes and mosquito-borne pathogens using highly multiplexed serology.

Science advances·2026
Same author

Safety and efficacy of the monoclonal antibody L9LS for malaria prevention in children exposed to perennial malaria transmission in Kenya: a randomised, double-blind, placebo-controlled, phase 2 trial.

Lancet (London, England)·2026
Same author

Safety, Tolerability, and Pharmacokinetics of 6-Diazo-5-Oxo-L-Norleucine in Malawian Adults With and Without Malaria: A Phase 1 Dose-Escalation Clinical Trial.

The Journal of infectious diseases·2026
Same author

SIMPLseq: a high-sensitivity Plasmodium falciparum genotyping and PCR contamination tracking tool.

Malaria journal·2026

Related Experiment Video

Updated: May 7, 2026

Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay
09:57

Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay

Published on: August 6, 2020

Advances and challenges in malaria vaccine development.

Peter D Crompton1, Susan K Pierce, Louis H Miller

  • 1Laboratory of Immunogenetics, National Institute of Allergy and Infectious Disease (NIAID), NIH, Rockville, Maryland, USA.

The Journal of Clinical Investigation
|December 3, 2010
PubMed
Summary

Developing an effective malaria vaccine is crucial for public health, especially in Africa. Identifying new vaccine targets and understanding natural immunity are key to creating highly protective malaria vaccines.

More Related Videos

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

Generating Genetically Modified Plasmodium berghei Sporozoites
10:16

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

Related Experiment Videos

Last Updated: May 7, 2026

Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay
09:57

Measuring Naturally Acquired Phagocytosis-Inducing Antibodies to Plasmodium falciparum Parasites by a Flow Cytometry-Based Assay

Published on: August 6, 2020

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes
08:20

In Vitro Assay of Plasmodium-Infected Red Blood Cell Killing by Cytotoxic Lymphocytes

Published on: August 17, 2022

Generating Genetically Modified Plasmodium berghei Sporozoites
10:16

Generating Genetically Modified Plasmodium berghei Sporozoites

Published on: May 5, 2023

Area of Science:

  • Tropical medicine
  • Immunology
  • Vaccinology

Background:

  • Plasmodium falciparum malaria poses a significant global health challenge, particularly in Africa, disproportionately affecting children and pregnant women.
  • An effective malaria vaccine is essential for reducing disease burden and aiding malaria elimination efforts.
  • Current vaccine development focuses on parasite life cycle stages, but limited protein targets have been explored.

Purpose of the Study:

  • To highlight the urgent need for novel vaccine targets to improve malaria vaccine efficacy.
  • To emphasize the importance of understanding naturally acquired immunity for vaccine design.

Main Methods:

  • Review of current malaria vaccine research and development landscape.
  • Analysis of challenges in developing effective malaria vaccines.
  • Exploration of naturally acquired immunity as a source of vaccine insights.

Main Results:

  • The RTS,S vaccine candidate shows partial efficacy and is in advanced clinical trials.
  • Few parasite proteins have been investigated as potential vaccine targets.
  • Understanding natural immunity mechanisms is critical for future vaccine strategies.

Conclusions:

  • New vaccine targets are imperative for developing highly effective malaria vaccines.
  • Further research into naturally acquired immunity can inform rational vaccine design.
  • A comprehensive approach combining target identification and immunity understanding is needed.